Kelsey Barcomb

Kelsey Barcomb

Auto-generated profile, based on publicly available information

Kelsey Barcomb

Department of Pharmacology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2025 in Nature
Verified
Journal Article
Closed access
PDF file
ALAndrew T. Luskin
Andrew T. Luskin
LLLi Li
Li Li
XFXiaonan Fu
Xiaonan Fu
MMMadison M. Martin
Madison M. Martin
KBKelsey Barcomb
Kelsey Barcomb
MBMichael R. Bruchas
Michael R. Bruchas

5 October 2023 in Experimental Neurology
Verified
Journal Article
Open access
KBKelsey Barcomb
Kelsey Barcomb
CFChristopher P. Ford
Christopher P. Ford
Parkinson's disease is a neurological disorder characterized by degeneration of midbrain dopamine neurons, which results in numerous adaptations in basal ganglia circuits. Research over the past twenty-five years has identified that midbrain dopamine neurons of the substantia nigra pars compacta (SNc) and ventral tegmental area (VTA) co-release multiple other transmitters including glutamate and GABA, in addition to their canonical transmitter, dopamine. This review summarizes previous work characterizing neurotransmitter co-release from dopamine neurons, work examining potential changes in co-release dynamics that result in animal models of Parkinson's disease, and future opportunities for determining how dysfunction in co-release may contribute to circuit dysfunction in Parkinson's disease.

4 July 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
ALAndrew T. Luskin
Andrew T. Luskin
LLLi Li
Li Li
XFXiaonan Fu
Xiaonan Fu
MMMadison M. Martin
Madison M. Martin
KBKelsey Barcomb
Kelsey Barcomb
MBMichael R. Bruchas
Michael R. Bruchas
As the primary source of norepinephrine (NE) in the brain, the locus coeruleus (LC) regulates arousal, avoidance and stress responses 1,2 . However, how local neuromodulatory inputs control LC function remains unresolved. Here we identify a population of transcriptionally, spatially and functionally diverse GABAergic neurons in the LC dendritic field that receive distant inputs and modulate modes of LC firing to control global arousal levels and arousal-related processing and behaviors. We define peri-LC anatomy using viral tracing and combine single-cell RNA sequencing with spatial transcriptomics to molecularly define both LC-NE and peri-LC cell types. We identify several neuronal cell types which underlie peri-LC functional diversity using a series of complementary neural circuit approaches in behaving mice. Our findings indicate that LC and peri-LC neurons are transcriptionally, functionally, and anatomically heterogenous neuronal populations which modulate arousal and avoidance states. Defining the molecular, cellular, and functional diversity of the LC and peri-LC provides a road map for understanding the neurobiological basis of arousal, motivation and neuropsychiatric disorders.

18 March 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
KBKelsey Barcomb
Kelsey Barcomb
JHJen-Tsiang T. Hsiao
Jen-Tsiang T. Hsiao
JLJulia Lemak
Julia Lemak
XZXiaomei Zhuang
Xiaomei Zhuang
BCBerenice Coutant
Berenice Coutant
ANAlexandra Nelson
Alexandra Nelson
It has proven challenging to faithfully recapitulate the key pathological, physiological, and behavioral features of Parkinson’s Disease (PD) in animals. Here we used adeno-associated virus (AAV) vectors to achieve cell type-specific overexpression of wild-type human α -synuclein ( α syn) and a fluorophore (mCherry) in midbrain dopamine neurons to model PD in mice. We found that AAVs drove selective expression of both α syn and mCherry in midbrain dopamine neurons. In conjunction with approximately 2-fold overexpression of α syn, we found several histopathological markers of PD-like pathology, including progressive accumulation of phosphorylated and aggregated α syn, ubiquitin, and a reduction in the expression of tyrosine hydroxylase, without overt cell loss. In parallel, α syn overexpression drove a profound loss of evoked dopamine release, without a substantive change in the intrinsic properties of dopamine neurons, nor in striatal dopamine content. Finally, α syn overexpression led to mild locomotor deficits. Together, these findings suggest that moderate α syn overexpression can mimic some aspects of premotor and early symptomatic phases of PD, including markers of Lewy Body-like pathology and functional loss of evoked dopamine release. This model may be useful for investigating cellular and circuit mechanisms related to PD pathogenesis and progression.